Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Kimberly J Popovits. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Kimberly J Popovits har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:KNSA / Kiniksa Pharmaceuticals, Ltd. | Director | 12 546 |
US:EXAS / Exact Sciences Corporation | Director | 16 381 |
US:TXG / 10x Genomics, Inc. | Director | 28 616 |
US:TLIS / Talis Biomedical Corporation | Interim CEO | 550 000 |
Director | 0 | |
US:GHDX / Genomic Health, Inc. | President and CEO, Director | 0 |
US:ZSPH / ZS Pharma, Inc. | Director | 0 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Kimberly J Popovits. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp KNSA / Kiniksa Pharmaceuticals, Ltd. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i KNSA / Kiniksa Pharmaceuticals, Ltd.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i KNSA / Kiniksa Pharmaceuticals, Ltd.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till min |
Pris vid min |
Maximal förlust undvikits ($) |
Maximal förlust undvikits ($) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderköp TLIS / Talis Biomedical Corporation - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i KNSA / Kiniksa Pharmaceuticals, Ltd.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
---|---|---|---|---|---|---|---|---|---|---|---|
2021-02-17 | TLIS | Popovits Kimberly J | 5 300 | 16,0000 | 353 | 240,0000 | 84 800 | 1 | 5510.25 | 1 860 318 | 2 193,77 |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i KNSA / Kiniksa Pharmaceuticals, Ltd.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till min |
Pris vid min |
Maximal förlust undvikits ($) |
Maximal förlust undvikits ($) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderköp TXG / 10x Genomics, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i KNSA / Kiniksa Pharmaceuticals, Ltd.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i KNSA / Kiniksa Pharmaceuticals, Ltd.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till min |
Pris vid min |
Maximal förlust undvikits ($) |
Maximal förlust undvikits ($) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Kimberly J Popovits som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-08-01 |
|
4 | KNSA |
Kiniksa Pharmaceuticals International, plc
Class A Ordinary Share |
M - Exercise | −64 508 | 12 546 | −83,72 | 29,90 | −1 928 789 | 375 125 | |
2025-08-01 |
|
4 | KNSA |
Kiniksa Pharmaceuticals International, plc
Class A Ordinary Share |
M - Exercise | 18 760 | 77 054 | 32,18 | 15,47 | 290 217 | 1 192 025 | |
2025-08-01 |
|
4 | KNSA |
Kiniksa Pharmaceuticals International, plc
Class A Ordinary Share |
M - Exercise | 45 748 | 58 294 | 364,64 | 10,36 | 473 949 | 603 926 | |
2025-06-16 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
A - Award | 9 994 | 16 381 | 156,47 | ||||
2025-06-05 |
|
4 | KNSA |
Kiniksa Pharmaceuticals International, plc
Class A Ordinary Share |
M - Exercise | 3 173 | 12 546 | 33,85 | ||||
2025-06-05 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
A - Award | 15 357 | 28 616 | 115,82 | ||||
2025-01-06 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
A - Award | 6 387 | 6 387 | |||||
2024-06-13 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
A - Award | 8 649 | 13 259 | 187,61 | ||||
2024-06-07 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Share |
M - Exercise | 4 373 | 9 373 | 87,46 | ||||
2023-07-03 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Share |
M - Exercise | 5 000 | 5 000 | |||||
2023-06-16 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
A - Award | 1 865 | 4 610 | 67,94 | ||||
2022-06-17 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
A - Award | 2 120 | 2 745 | 339,20 | ||||
2021-08-31 |
|
4 | TLIS |
Talis Biomedical Corp
Stock Option (right to buy) |
A - Award | 550 000 | 550 000 | |||||
2021-06-30 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Share Option |
A - Award | 33 237 | 33 237 | |||||
2021-06-15 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
A - Award | 1 563 | 1 563 | |||||
2021-06-15 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
A - Award | 625 | 625 | |||||
2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series F-1 Preferred Stock |
C - Conversion | −128 655 | 0 | −100,00 | ||||
2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series E-1 Preferred Stock |
C - Conversion | −131 642 | 0 | −100,00 | ||||
2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series E-1 Preferred Stock |
C - Conversion | −300 000 | 0 | −100,00 | ||||
2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series C-1 Preferred Stock |
C - Conversion | −31 519 | 0 | −100,00 | ||||
2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Common Stock |
C - Conversion | 89 968 | 182 025 | 97,73 | ||||
2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Common Stock |
C - Conversion | 92 057 | 92 057 | |||||
2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Common Stock |
P - Purchase | 5 300 | 215 090 | 2,53 | 16,00 | 84 800 | 3 441 440 | |
2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Common Stock |
C - Conversion | 209 790 | 209 790 | |||||
2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Common Stock |
C - Conversion | 22 041 | 25 776 | 590,12 | ||||
2021-02-11 | 3 | TLIS |
Talis Biomedical Corp
Common Stock |
3 735 | ||||||||
2020-11-19 |
|
4 | MYOK |
MyoKardia, Inc.
Stock Option (Right to buy) |
D - Sale to Issuer | −3 000 | 0 | −100,00 | ||||
2020-11-19 |
|
4 | MYOK |
MyoKardia, Inc.
Stock Option (Right to buy) |
D - Sale to Issuer | −6 600 | 0 | −100,00 | ||||
2020-11-19 |
|
4 | MYOK |
MyoKardia, Inc.
Stock Option (Right to buy) |
D - Sale to Issuer | −11 000 | 0 | −100,00 | ||||
2020-11-19 |
|
4 | MYOK |
MyoKardia, Inc.
Stock Option (Right to buy) |
D - Sale to Issuer | −11 000 | 0 | −100,00 | ||||
2020-11-19 |
|
4 | MYOK |
MyoKardia, Inc.
Stock Option (Right to buy) |
D - Sale to Issuer | −22 000 | 0 | −100,00 | ||||
2020-11-19 |
|
4 | MYOK |
MyoKardia, Inc.
Common Stock |
U - Other | −4 100 | 0 | −100,00 | ||||
2020-07-02 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Share Option |
A - Award | 18 760 | 18 760 | |||||
2020-06-22 |
|
4 | MYOK |
MyoKardia, Inc.
Restricted Stock Units |
A - Award | 1 800 | 1 800 | |||||
2020-06-22 |
|
4 | MYOK |
MyoKardia, Inc.
Stock Option (Right to Buy) |
A - Award | 3 000 | 3 000 | |||||
2020-06-17 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
A - Award | 4 432 | 4 432 | |||||
2020-06-16 |
|
4 | MYOK |
MyoKardia, Inc.
Restricted Stock Units |
M - Exercise | 2 300 | 0 | −100,00 | ||||
2020-06-16 |
|
4 | MYOK |
MyoKardia, Inc.
Common Stock |
M - Exercise | 2 300 | 2 300 | |||||
2020-03-27 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
A - Award | 10 330 | 10 330 | |||||
2019-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) Holding |
D - Sale to Issuer | −75 610 | 0 | −100,00 | ||||
2019-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) Holding |
D - Sale to Issuer | −92 869 | 0 | −100,00 | ||||
2019-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) Holding |
D - Sale to Issuer | −72 231 | 92 869 | −43,75 | ||||
2019-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) Holding |
D - Sale to Issuer | −59 844 | 0 | −100,00 | ||||
2019-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) Holding |
D - Sale to Issuer | −131 656 | 59 844 | −68,75 | ||||
2019-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) Holding |
D - Sale to Issuer | −12 822 | 0 | −100,00 | ||||
2019-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) Holding |
D - Sale to Issuer | −141 038 | 12 822 | −91,67 | ||||
2019-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
D - Sale to Issuer | −100 000 | 0 | −100,00 | ||||
2019-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
D - Sale to Issuer | −67 500 | 0 | −100,00 | ||||
2019-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
D - Sale to Issuer | −36 168 | 0 | −100,00 | ||||
2019-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
D - Sale to Issuer | −68 268 | 0 | −100,00 | ||||
2019-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
D - Sale to Issuer | −12 298 | 0 | −100,00 | ||||
2019-10-09 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −10 000 | 68 268 | −12,78 | 67,74 | −677 364 | 4 624 229 |
2019-09-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −600 | 78 268 | −0,76 | 74,10 | −44 460 | 5 799 596 |
2019-09-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −2 483 | 78 868 | −3,05 | 73,35 | −182 125 | 5 784 873 |
2019-09-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −6 917 | 81 351 | −7,84 | 72,10 | −498 700 | 5 865 228 |
2019-09-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
G - Gift | −10 200 | 88 268 | −10,36 | ||||
2019-08-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −15 000 | 0 | −100,00 | ||||
2019-08-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −5 091 | 98 468 | −4,92 | 74,67 | −380 162 | 7 352 940 |
2019-08-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −4 909 | 103 559 | −4,53 | 73,72 | −361 903 | 7 634 618 |
2019-08-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −7 607 | 108 468 | −6,55 | 74,68 | −568 092 | 8 100 412 |
2019-08-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −7 393 | 116 075 | −5,99 | 73,72 | −545 042 | 8 557 513 |
2019-08-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 15 000 | 123 468 | 13,83 | 29,34 | 440 100 | 3 622 551 | |
2019-08-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −25 000 | 15 000 | −62,50 | ||||
2019-08-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −447 | 108 468 | −0,41 | 73,76 | −32 970 | 8 000 470 |
2019-08-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −24 553 | 108 915 | −18,40 | 73,30 | −1 799 683 | 7 983 241 |
2019-08-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 25 000 | 133 468 | 23,05 | 29,34 | 733 500 | 3 915 951 | |
2019-08-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −25 000 | 40 000 | −38,46 | ||||
2019-08-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −1 000 | 108 468 | −0,91 | 74,37 | −74 369 | 8 066 668 |
2019-08-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −24 000 | 109 468 | −17,98 | 73,63 | −1 767 173 | 8 060 370 |
2019-08-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 25 000 | 133 468 | 23,05 | 29,34 | 733 500 | 3 915 951 | |
2019-08-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −25 000 | 65 000 | −27,78 | ||||
2019-08-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −9 235 | 108 468 | −7,85 | 74,23 | −685 470 | 8 051 059 |
2019-08-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −15 765 | 117 703 | −11,81 | 73,63 | −1 160 796 | 8 666 613 |
2019-08-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 25 000 | 133 468 | 23,05 | 29,34 | 733 500 | 3 915 951 | |
2019-08-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
G - Gift | −800 | 108 152 | −0,73 | ||||
2019-06-17 |
|
4 | MYOK |
MyoKardia Inc
Restricted Stock Units |
A - Award | 2 300 | 2 300 | |||||
2019-06-17 |
|
4 | MYOK |
MyoKardia Inc
Stock Option (Right to Buy) |
A - Award | 6 600 | 6 600 | |||||
2019-05-30 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Share Option |
A - Award | 18 760 | 18 760 | |||||
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −100 | 108 952 | −0,09 | 68,31 | −6 831 | 7 442 511 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −2 364 | 109 052 | −2,12 | 67,54 | −159 676 | 7 365 917 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −7 536 | 111 416 | −6,34 | 66,72 | −502 814 | 7 433 854 |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
G - Gift | −7 000 | 118 952 | −5,56 | ||||
2019-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −847 | 125 952 | −0,67 | 73,71 | −62 434 | 9 284 098 |
2019-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −9 153 | 126 799 | −6,73 | 73,18 | −669 804 | 9 278 973 |
2019-02-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
F - Taxes | −12 890 | 55 138 | −18,95 | 83,34 | −1 074 253 | 4 595 201 | |
2019-02-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −47 900 | 0 | −100,00 | ||||
2019-02-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −13 900 | 116 982 | −10,62 | 82,30 | −1 143 948 | 9 627 431 |
2019-02-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −34 000 | 130 882 | −20,62 | 81,46 | −2 769 667 | 10 661 752 |
2019-02-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 47 900 | 164 882 | 40,95 | 17,18 | 822 922 | 2 832 673 | |
2019-01-31 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) Holding |
A - Award | 75 610 | 75 610 | |||||
2019-01-31 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 10 960 | 68 028 | 19,21 | ||||
2018-12-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −3 722 | 116 982 | −3,08 | 67,46 | −251 102 | 7 892 097 |
2018-12-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −17 208 | 120 704 | −12,48 | 66,74 | −1 148 433 | 8 055 580 |
2018-12-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −4 070 | 137 912 | −2,87 | 65,79 | −267 751 | 9 072 748 |
2018-12-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −1 200 | 141 982 | −0,84 | 68,53 | −82 233 | 9 729 686 |
2018-12-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −7 014 | 143 182 | −4,67 | 67,89 | −476 184 | 9 720 698 |
2018-12-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −9 079 | 150 196 | −5,70 | 66,78 | −606 340 | 10 030 825 |
2018-12-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −7 707 | 159 275 | −4,62 | 65,85 | −507 484 | 10 487 813 |
2018-12-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
G - Gift | −589 | 57 068 | −1,02 | ||||
2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −946 | 166 982 | −0,56 | 77,93 | −73 720 | 13 012 540 |
2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −3 199 | 167 928 | −1,87 | 77,11 | −246 685 | 12 949 465 |
2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −5 855 | 171 127 | −3,31 | 76,31 | −446 766 | 13 057 863 |
2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
G - Gift | −1 860 | 57 657 | −3,13 | ||||
2018-11-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −15 000 | 0 | −100,00 | ||||
2018-11-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −1 400 | 176 982 | −0,78 | 77,90 | −109 067 | 13 787 783 |
2018-11-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −4 939 | 178 382 | −2,69 | 77,10 | −380 814 | 13 753 877 |
2018-11-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −8 661 | 183 321 | −4,51 | 76,31 | −660 912 | 13 989 042 |
2018-11-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 15 000 | 191 982 | 8,48 | 22,98 | 344 700 | 4 411 746 | |
2018-11-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −25 000 | 15 000 | −62,50 | ||||
2018-11-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −10 083 | 176 982 | −5,39 | 78,69 | −793 390 | 13 925 988 |
2018-11-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −2 854 | 187 065 | −1,50 | 77,56 | −221 349 | 14 508 275 |
2018-11-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −5 138 | 189 919 | −2,63 | 76,89 | −395 072 | 14 603 271 |
2018-11-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −1 925 | 195 057 | −0,98 | 75,78 | −145 880 | 14 781 771 |
2018-11-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −5 000 | 196 982 | −2,48 | 74,77 | −373 870 | 14 729 132 |
2018-11-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 25 000 | 201 982 | 14,13 | 22,98 | 574 500 | 4 641 546 | |
2018-10-17 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −25 000 | 40 000 | −38,46 | ||||
2018-10-17 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −7 885 | 176 982 | −4,27 | 67,39 | −531 340 | 11 926 144 |
2018-10-17 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −8 217 | 184 867 | −4,26 | 66,43 | −545 836 | 12 280 290 |
2018-10-17 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −6 103 | 193 084 | −3,06 | 65,41 | −399 221 | 12 630 377 |
2018-10-17 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −2 795 | 199 187 | −1,38 | 64,45 | −180 127 | 12 836 825 |
2018-10-17 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 25 000 | 201 982 | 14,13 | 22,98 | 574 500 | 4 641 546 | |
2018-10-17 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −25 000 | 65 000 | −27,78 | ||||
2018-10-17 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −400 | 176 982 | −0,23 | 65,76 | −26 304 | 11 638 336 |
2018-10-17 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −880 | 177 382 | −0,49 | 64,79 | −57 014 | 11 492 331 |
2018-10-17 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −23 720 | 178 262 | −11,74 | 64,26 | −1 524 323 | 11 455 687 |
2018-10-17 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 25 000 | 201 982 | 14,13 | 22,98 | 574 500 | 4 641 546 | |
2018-08-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −1 000 | 176 982 | −0,56 | 53,68 | −53 684 | 9 501 102 |
2018-08-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −50 550 | 177 982 | −22,12 | 52,70 | −2 663 788 | 9 378 957 |
2018-08-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −8 450 | 228 532 | −3,57 | 51,92 | −438 731 | 11 865 564 |
2018-07-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −10 000 | 47 900 | −17,27 | ||||
2018-07-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −7 001 | 236 157 | −2,88 | 53,54 | −374 813 | 12 643 161 |
2018-07-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −2 999 | 243 158 | −1,22 | 52,64 | −157 871 | 12 800 153 |
2018-07-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 10 000 | 246 157 | 4,23 | 17,18 | 171 800 | 4 228 977 | |
2018-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −10 000 | 57 900 | −14,73 | ||||
2018-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −400 | 236 157 | −0,17 | 49,76 | −19 902 | 11 749 992 |
2018-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −9 600 | 236 557 | −3,90 | 48,86 | −469 014 | 11 557 134 |
2018-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 10 000 | 246 157 | 4,23 | 17,18 | 171 800 | 4 228 977 | |
2018-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
G - Gift | −100 | 59 517 | −0,17 | ||||
2018-06-14 |
|
4 | MYOK |
MyoKardia Inc
Stock Option (Right to Buy) |
A - Award | 11 000 | 11 000 | |||||
2018-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −5 000 | 67 900 | −6,86 | ||||
2018-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −5 000 | 67 900 | −6,86 | ||||
2018-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −5 000 | 236 157 | −2,07 | 38,09 | −190 456 | 8 995 527 |
2018-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −5 000 | 241 157 | −2,03 | 38,08 | −190 420 | 9 184 247 |
2018-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 5 000 | 246 157 | 2,07 | 17,18 | 85 900 | 4 228 977 | |
2018-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 5 000 | 246 157 | 2,07 | 17,18 | 85 900 | 4 228 977 | |
2018-04-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −15 000 | 77 900 | −16,15 | ||||
2018-04-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −15 000 | 236 157 | −5,97 | 33,19 | −497 880 | 7 838 523 |
2018-04-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 15 000 | 251 157 | 6,35 | 17,18 | 257 700 | 4 314 877 | |
2018-03-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −5 000 | 92 900 | −5,11 | ||||
2018-03-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −5 000 | 236 157 | −2,07 | 32,01 | −160 048 | 7 559 291 |
2018-03-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 5 000 | 241 157 | 2,12 | 17,18 | 85 900 | 4 143 077 | |
2018-03-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
G - Gift | −1 155 | 236 157 | −0,49 | ||||
2018-02-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
F - Taxes | −6 232 | 59 617 | −9,46 | 32,66 | −203 537 | 1 947 091 | |
2018-02-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −10 000 | 97 900 | −9,27 | ||||
2018-02-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −10 000 | 65 849 | −13,18 | 32,93 | −329 336 | 2 168 645 |
2018-02-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 10 000 | 75 849 | 15,19 | 17,18 | 171 800 | 1 303 086 | |
2018-02-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) Holding |
A - Award | 165 100 | 165 100 | |||||
2018-02-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 23 930 | 65 849 | 57,09 | ||||
2018-01-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −200 | 107 900 | −0,19 | ||||
2018-01-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −9 800 | 108 100 | −8,31 | ||||
2018-01-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −200 | 41 919 | −0,47 | 35,70 | −7 140 | 1 496 508 |
2018-01-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 200 | 42 119 | 0,48 | 17,18 | 3 436 | 723 604 | |
2018-01-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −9 800 | 41 919 | −18,95 | 34,97 | −342 745 | 1 466 075 |
2018-01-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 9 800 | 51 719 | 23,38 | 17,18 | 168 364 | 888 532 | |
2017-12-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −7 100 | 117 900 | −5,68 | ||||
2017-12-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −12 900 | 0 | −100,00 | ||||
2017-12-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −10 000 | 41 919 | −19,26 | 33,00 | −330 000 | 1 383 327 |
2017-12-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −10 000 | 51 919 | −16,15 | 30,00 | −300 000 | 1 557 570 |
2017-12-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 7 100 | 61 919 | 12,95 | 17,18 | 121 978 | 1 063 768 | |
2017-12-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 12 900 | 54 819 | 30,77 | 17,33 | 223 557 | 950 013 | |
2017-09-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −5 000 | 32 900 | −13,19 | ||||
2017-09-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −5 000 | 41 132 | −10,84 | 31,00 | −154 989 | 1 275 002 |
2017-09-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 5 000 | 46 132 | 12,16 | 17,33 | 86 650 | 799 468 | |
2017-08-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −5 000 | 37 900 | −11,66 | ||||
2017-08-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −5 000 | 79 057 | −5,95 | 30,22 | −151 111 | 2 389 276 |
2017-08-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 5 000 | 84 057 | 6,32 | 17,33 | 86 650 | 1 456 708 | |
2017-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −1 468 | 42 900 | −3,31 | ||||
2017-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −1 468 | 79 057 | −1,82 | 32,67 | −47 952 | 2 582 405 |
2017-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 1 468 | 80 525 | 1,86 | 17,33 | 25 440 | 1 395 498 | |
2017-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −3 532 | 44 368 | −7,37 | ||||
2017-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −3 532 | 79 057 | −4,28 | 32,56 | −114 988 | 2 573 788 |
2017-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 3 532 | 82 589 | 4,47 | 17,33 | 61 210 | 1 431 267 | |
2017-06-16 |
|
4 | MYOK |
MyoKardia Inc
Stock Option (Right to Buy) |
A - Award | 11 000 | 11 000 | |||||
2017-06-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −5 000 | 47 900 | −9,45 | ||||
2017-06-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
G - Gift | −100 | 199 387 | −0,05 | ||||
2017-06-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −5 000 | 79 057 | −5,95 | 32,32 | −161 582 | 2 554 838 |
2017-06-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 5 000 | 84 057 | 6,32 | 17,33 | 86 650 | 1 456 708 | |
2017-05-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −2 293 | 52 900 | −4,15 | ||||
2017-05-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −2 707 | 55 193 | −4,68 | ||||
2017-05-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −2 293 | 78 236 | −2,85 | 31,96 | −73 279 | 2 500 227 |
2017-05-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −2 707 | 80 529 | −3,25 | 31,61 | −85 570 | 2 545 578 |
2017-05-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 2 293 | 83 236 | 2,83 | 17,33 | 39 738 | 1 442 480 | |
2017-05-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 2 707 | 80 943 | 3,46 | 17,33 | 46 912 | 1 402 742 | |
2017-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −2 100 | 57 900 | −3,50 | ||||
2017-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −2 900 | 0 | −100,00 | ||||
2017-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −5 000 | 78 236 | −6,01 | 31,30 | −156 506 | 2 448 889 |
2017-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 2 100 | 83 236 | 2,59 | 17,33 | 36 393 | 1 442 480 | |
2017-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 2 900 | 81 136 | 3,71 | 23,31 | 67 599 | 1 891 280 | |
2017-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
G - Gift | −488 | 199 487 | −0,24 | ||||
2017-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
G - Gift | −876 | 199 975 | −0,44 | ||||
2017-03-17 |
|
4 | MYOK |
MyoKardia Inc
Stock Option (Right to Buy) |
A - Award | 22 000 | 22 000 | |||||
2017-03-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −290 | 2 900 | −9,09 | ||||
2017-03-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −290 | 78 236 | −0,37 | 31,08 | −9 014 | 2 431 872 |
2017-03-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 290 | 78 526 | 0,37 | 23,31 | 6 760 | 1 830 441 | |
2017-03-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −4 710 | 3 190 | −59,62 | ||||
2017-03-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −4 710 | 78 236 | −5,68 | 31,09 | −146 440 | 2 432 467 |
2017-03-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 4 710 | 82 946 | 6,02 | 23,31 | 109 790 | 1 933 471 | |
2017-02-17 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
F - Taxes | −4 982 | 78 236 | −5,99 | 31,12 | −155 040 | 2 434 704 | |
2017-02-15 |
|
5 | GHDX |
GENOMIC HEALTH INC
Common Stock |
G - Gift | −900 | 55 458 | −1,60 | ||||
2017-02-15 |
|
5 | GHDX |
GENOMIC HEALTH INC
Common Stock |
G - Gift | −3 262 | 56 358 | −5,47 | ||||
2017-02-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) Holding |
A - Award | 191 500 | 191 500 | |||||
2017-02-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 27 760 | 87 380 | 46,56 | ||||
2016-12-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −5 000 | 7 900 | −38,76 | ||||
2016-12-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −5 000 | 59 620 | −7,74 | 30,02 | −150 100 | 1 789 792 |
2016-12-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 5 000 | 64 620 | 8,39 | 23,31 | 116 550 | 1 506 292 | |
2016-11-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −5 313 | 0 | −100,00 | ||||
2016-11-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −5 313 | 59 620 | −8,18 | 28,88 | −153 423 | 1 721 641 |
2016-11-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 5 313 | 64 933 | 8,91 | 18,89 | 100 363 | 1 226 584 | |
2016-11-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
G - Gift | −1 050 | 200 851 | −0,52 | ||||
2016-11-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
G - Gift | −1 100 | 201 901 | −0,54 | ||||
2016-02-17 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) Holding |
A - Award | 153 860 | 153 860 | |||||
2016-02-17 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 26 300 | 58 796 | 80,93 | ||||
2016-02-17 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
F - Taxes | −3 195 | 32 496 | −8,95 | 26,53 | −84 763 | 862 119 | |
2016-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −5 000 | 5 313 | −48,48 | ||||
2016-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −5 000 | 35 691 | −12,29 | 30,34 | −151 680 | 1 082 719 |
2016-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 5 000 | 40 691 | 14,01 | 18,89 | 94 450 | 768 653 | |
2015-12-21 |
|
4 | ZSPH |
ZS Pharma, Inc.
Stock Options (NQ) - BOD 6/18/15 |
D - Sale to Issuer | −4 000 | 0 | −100,00 | ||||
2015-12-21 |
|
4 | ZSPH |
ZS Pharma, Inc.
Stock Options (NQ) - 5/1/15 |
D - Sale to Issuer | −12 000 | 0 | −100,00 | ||||
2015-12-21 |
|
4 | ZSPH |
ZS Pharma, Inc.
Common Stock |
D - Sale to Issuer | −1 000 | 0 | −100,00 | 90,00 | −90 000 | ||
2015-12-17 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −5 000 | 10 313 | −32,65 | ||||
2015-12-17 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −5 000 | 35 691 | −12,29 | 30,00 | −150 000 | 1 070 730 |
2015-12-17 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 5 000 | 40 691 | 14,01 | 18,89 | 94 450 | 768 653 | |
2015-06-25 |
|
4 | ZSPH |
ZS Pharma, Inc.
Restricted Stock Unit |
A - Award | 1 000 | 1 000 | |||||
2015-06-25 |
|
4 | ZSPH |
ZS Pharma, Inc.
Stock Options right to buy |
A - Award | 4 000 | 4 000 | 55,57 | 222 280 | 222 280 | ||
2015-04-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −3 000 | 15 313 | −16,38 | ||||
2015-04-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −3 000 | 34 939 | −7,91 | 31,28 | −93 840 | 1 092 888 |
2015-04-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 3 000 | 37 939 | 8,59 | 18,89 | 56 670 | 716 668 | |
2015-03-17 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −3 000 | 18 313 | −14,08 | ||||
2015-03-17 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −3 000 | 34 939 | −7,91 | 31,91 | −95 717 | 1 114 757 |
2015-03-17 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 3 000 | 37 939 | 8,59 | 18,89 | 56 670 | 716 668 | |
2015-03-17 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
G - Gift | −500 | 203 001 | −0,25 | ||||
2015-03-17 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
G - Gift | −500 | 203 001 | −0,25 | ||||
2015-03-17 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
G - Gift | −500 | 203 001 | −0,25 | ||||
2015-03-17 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
G - Gift | −100 | 203 501 | −0,05 | ||||
2015-02-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
F - Taxes | −4 456 | 34 939 | −11,31 | ||||
2015-02-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 2 430 | 39 395 | 6,57 | ||||
2015-02-17 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −3 000 | 21 313 | −12,34 | ||||
2015-02-17 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −3 000 | 36 965 | −7,51 | 29,86 | −89 566 | 1 103 601 |
2015-02-17 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 3 000 | 39 965 | 8,12 | 18,89 | 56 670 | 754 939 | |
2015-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −3 000 | 24 313 | −10,98 | ||||
2015-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −3 000 | 36 965 | −7,51 | 33,46 | −100 386 | 1 236 927 |
2015-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 3 000 | 39 965 | 8,12 | 18,89 | 56 670 | 754 939 | |
2014-12-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −600 | 27 313 | −2,15 | ||||
2014-12-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −2 400 | 27 913 | −7,92 | ||||
2014-12-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −600 | 36 965 | −1,60 | 33,22 | −19 934 | 1 228 099 |
2014-12-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 600 | 37 565 | 1,62 | 18,89 | 11 334 | 709 603 | |
2014-12-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −2 400 | 36 965 | −6,10 | 32,93 | −79 033 | 1 217 280 |
2014-12-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 2 400 | 39 365 | 6,49 | 18,89 | 45 336 | 743 605 | |
2014-12-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
G - Gift | −600 | 204 601 | −0,29 | ||||
2014-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −2 100 | 30 313 | −6,48 | ||||
2014-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −2 200 | 32 413 | −6,36 | ||||
2014-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −2 100 | 36 965 | −5,38 | 35,37 | −74 281 | 1 307 522 |
2014-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 2 100 | 39 065 | 5,68 | 18,89 | 39 669 | 737 938 | |
2014-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −2 200 | 36 965 | −5,62 | 34,29 | −75 428 | 1 267 360 |
2014-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 2 200 | 39 165 | 5,95 | 18,89 | 41 558 | 739 827 | |
2014-10-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −3 000 | 34 613 | −7,98 | ||||
2014-10-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −3 000 | 36 965 | −7,51 | 30,78 | −92 326 | 1 137 613 |
2014-10-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 3 000 | 39 965 | 8,12 | 18,89 | 56 670 | 754 939 | |
2014-09-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −2 387 | 37 613 | −5,97 | ||||
2014-09-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −613 | 0 | −100,00 | ||||
2014-09-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −3 000 | 36 965 | −7,51 | 29,82 | −89 446 | 1 102 126 |
2014-09-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 2 387 | 39 965 | 6,35 | 18,89 | 45 090 | 754 939 | |
2014-09-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 613 | 37 578 | 1,66 | 9,39 | 5 756 | 352 857 | |
2014-08-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −3 000 | 613 | −83,03 | ||||
2014-08-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −3 000 | 36 965 | −7,51 | 26,07 | −78 201 | 963 567 |
2014-08-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 3 000 | 39 965 | 8,12 | 9,39 | 28 170 | 375 271 | |
2014-07-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −3 000 | 3 613 | −45,37 | ||||
2014-07-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −3 000 | 36 965 | −7,51 | 26,59 | −79 777 | 982 981 |
2014-07-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 3 000 | 39 965 | 8,12 | 9,39 | 28 170 | 375 271 | |
2014-06-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −3 000 | 6 613 | −31,21 | ||||
2014-06-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −3 000 | 36 965 | −7,51 | 26,10 | −78 295 | 964 720 |
2014-06-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 3 000 | 39 965 | 8,12 | 9,39 | 28 170 | 375 271 | |
2014-06-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
G - Gift | −1 081 | 205 201 | −0,52 | ||||
2014-06-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
G - Gift | 1 081 | 16 825 | 6,87 | ||||
2014-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −391 | 9 613 | −3,91 | ||||
2014-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −2 609 | 10 004 | −20,69 | ||||
2014-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −391 | 36 255 | −1,07 | 27,10 | −10 596 | 982 485 |
2014-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −2 609 | 36 646 | −6,65 | 26,45 | −69 021 | 969 466 |
2014-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 391 | 39 255 | 1,01 | 9,39 | 3 671 | 368 604 | |
2014-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 2 609 | 38 864 | 7,20 | 9,39 | 24 499 | 364 933 | |
2014-02-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
F - Taxes | −1 128 | 36 255 | −3,02 | 27,62 | −31 155 | 1 001 363 | |
2014-02-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
F - Taxes | −1 253 | 37 383 | −3,24 | 27,62 | −34 608 | 1 032 518 | |
2014-02-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
F - Taxes | −1 230 | 38 636 | −3,09 | 27,62 | −33 973 | 1 067 126 | |
2014-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
A - Award | 100 000 | 100 000 | |||||
2014-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 13 000 | 39 866 | 48,39 | ||||
2014-01-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −2 500 | 12 613 | −16,54 | ||||
2014-01-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −2 500 | 26 866 | −8,51 | 30,00 | −75 000 | 805 980 |
2014-01-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 2 500 | 29 366 | 9,31 | 9,39 | 23 475 | 275 747 | |
2013-12-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −2 500 | 15 113 | −14,19 | ||||
2013-12-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −2 500 | 26 866 | −8,51 | 30,68 | −76 705 | 824 300 |
2013-12-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 2 500 | 29 366 | 9,31 | 9,39 | 23 475 | 275 747 | |
2013-12-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
G - Gift | −400 | 206 282 | −0,19 | ||||
2013-12-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
G - Gift | −400 | 206 282 | −0,19 | ||||
2013-12-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
G - Gift | −350 | 207 082 | −0,17 | ||||
2013-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −2 500 | 17 613 | −12,43 | ||||
2013-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −2 500 | 26 866 | −8,51 | 35,00 | −87 500 | 940 310 |
2013-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 2 500 | 29 366 | 9,31 | 9,39 | 23 475 | 275 747 | |
2013-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −2 500 | 20 113 | −11,06 | ||||
2013-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −2 500 | 26 866 | −8,51 | 34,17 | −85 423 | 917 992 |
2013-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 2 500 | 29 366 | 9,31 | 9,39 | 23 475 | 275 747 | |
2013-10-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −734 | 22 613 | −3,14 | ||||
2013-10-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −1 766 | 1 | −99,94 | ||||
2013-10-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −2 500 | 26 866 | −8,51 | 30,00 | −75 000 | 805 980 |
2013-10-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 734 | 29 366 | 2,56 | 9,39 | 6 892 | 275 747 | |
2013-10-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 1 766 | 28 632 | 6,57 | 2,88 | 5 086 | 82 460 | |
2013-09-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −2 500 | 1 767 | −58,59 | ||||
2013-09-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −2 500 | 26 866 | −8,51 | 34,31 | −85 787 | 921 901 |
2013-09-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 2 500 | 29 366 | 9,31 | 2,88 | 7 200 | 84 574 | |
2013-08-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −2 500 | 4 267 | −36,94 | ||||
2013-08-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −2 500 | 26 866 | −8,51 | 33,03 | −82 572 | 887 357 |
2013-08-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 2 500 | 29 366 | 9,31 | 2,88 | 7 200 | 84 574 | |
2013-07-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 9 000 | 26 866 | 50,38 | ||||
2013-07-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −2 100 | 6 767 | −23,68 | ||||
2013-07-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −2 100 | 17 866 | −10,52 | 35,00 | −73 500 | 625 310 |
2013-07-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 2 100 | 19 966 | 11,75 | 2,88 | 6 048 | 57 502 | |
2013-07-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −2 900 | 8 867 | −24,65 | ||||
2013-07-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −2 900 | 17 866 | −13,97 | 34,32 | −99 528 | 613 161 |
2013-07-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 2 900 | 20 766 | 16,23 | 2,88 | 8 352 | 59 806 | |
2013-06-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −2 500 | 11 767 | −17,52 | ||||
2013-06-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −2 500 | 11 767 | −17,52 | ||||
2013-06-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −2 500 | 17 866 | −12,28 | 35,68 | −89 212 | 637 545 |
2013-06-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 2 500 | 20 366 | 13,99 | 2,88 | 7 200 | 58 654 | |
2013-06-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 2 500 | 20 366 | 13,99 | 2,88 | 7 200 | 58 654 | |
2013-06-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −2 500 | 17 866 | −12,28 | 35,68 | −89 188 | 637 370 |
2013-05-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −2 500 | 16 767 | −12,98 | ||||
2013-05-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −2 500 | 16 767 | −12,98 | ||||
2013-05-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −2 500 | 16 963 | −12,84 | 35,00 | −87 500 | 593 705 |
2013-05-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 2 500 | 19 463 | 14,74 | 2,88 | 7 200 | 56 053 | |
2013-05-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 2 500 | 19 463 | 14,74 | 2,88 | 7 200 | 56 053 | |
2013-05-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −2 500 | 16 963 | −12,84 | 34,40 | −86 006 | 583 568 |
2013-04-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −2 500 | 21 767 | −10,30 | ||||
2013-04-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −2 500 | 16 963 | −12,84 | 30,00 | −75 000 | 508 890 |
2013-04-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 2 500 | 19 463 | 14,74 | 2,88 | 7 200 | 56 053 | |
2013-04-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
G - Gift | −974 | 207 432 | −0,47 | ||||
2013-04-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
G - Gift | 974 | 15 744 | 6,59 | ||||
2013-02-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
F - Taxes | −1 244 | 16 963 | −6,83 | 28,77 | −35 790 | 488 026 | |
2013-02-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
F - Taxes | −1 316 | 18 207 | −6,74 | 28,77 | −37 861 | 523 815 | |
2013-02-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
A - Award | 67 500 | 67 500 | |||||
2012-12-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −400 | 208 406 | −0,19 | 28,44 | −11 377 | 5 927 588 |
2012-12-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −4 600 | 208 806 | −2,16 | 27,73 | −127 578 | 5 791 088 |
2012-11-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −5 000 | 213 406 | −2,29 | 27,24 | −136 217 | 5 813 905 |
2012-10-17 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −5 000 | 12 900 | −27,93 | ||||
2012-10-17 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −5 000 | 19 523 | −20,39 | 35,00 | −175 000 | 683 305 |
2012-10-17 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 5 000 | 24 523 | 25,61 | 23,31 | 116 550 | 571 631 | |
2012-10-17 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −5 000 | 218 406 | −2,24 | 31,17 | −155 838 | 6 807 213 |
2012-09-17 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −5 000 | 223 406 | −2,19 | 31,69 | −158 450 | 7 079 736 |
2012-08-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −3 103 | 17 900 | −14,77 | ||||
2012-08-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −3 103 | 19 523 | −13,71 | 35,07 | −108 814 | 684 621 |
2012-08-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 3 103 | 22 626 | 15,89 | 23,31 | 72 331 | 527 412 | |
2012-08-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −1 897 | 21 003 | −8,28 | ||||
2012-08-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −5 000 | 228 406 | −2,14 | 34,39 | −171 936 | 7 854 220 |
2012-08-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −1 897 | 19 523 | −8,86 | 35,01 | −66 412 | 683 481 |
2012-08-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 1 897 | 21 420 | 9,72 | 23,31 | 44 219 | 499 300 | |
2012-07-17 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −2 100 | 22 900 | −8,40 | ||||
2012-07-17 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −2 100 | 19 523 | −9,71 | 35,03 | −73 570 | 683 959 |
2012-07-17 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 2 100 | 21 623 | 10,76 | 23,31 | 48 951 | 504 032 | |
2012-07-17 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −5 000 | 233 406 | −2,10 | 34,64 | −173 207 | 8 085 511 |
2012-06-19 |
|
4/A | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −5 000 | 238 406 | −2,05 | 33,36 | −166 806 | 7 953 486 |
2012-06-19 |
|
4/A | GHDX |
GENOMIC HEALTH INC
Common Stock |
G - Gift | −750 | 243 406 | −0,31 | ||||
2012-06-19 |
|
4/A | GHDX |
GENOMIC HEALTH INC
Common Stock |
G - Gift | −750 | 244 156 | −0,31 | ||||
2012-06-19 |
|
4/A | GHDX |
GENOMIC HEALTH INC
Common Stock |
G - Gift | −750 | 244 906 | −0,31 | ||||
2012-06-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −5 000 | 238 406 | −2,05 | 33,36 | −166 806 | 7 953 486 |
2012-06-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
G - Gift | −750 | 243 406 | −0,31 | ||||
2012-06-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
G - Gift | −750 | 243 406 | −0,31 | ||||
2012-06-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
G - Gift | −750 | 244 156 | −0,31 | ||||
2012-06-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 919 | 19 523 | 4,94 | 23,11 | 21 239 | 451 196 | |
2012-05-17 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
M - Exercise | −5 000 | 25 000 | −16,67 | ||||
2012-05-17 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −5 000 | 245 656 | −1,99 | 35,00 | −175 000 | 8 597 960 |
2012-05-17 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 5 000 | 250 656 | 2,04 | 23,31 | 116 550 | 5 842 791 | |
2012-05-17 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −5 000 | 245 656 | −1,99 | 33,46 | −167 292 | 8 219 257 |
2012-04-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −5 000 | 250 656 | −1,96 | 27,79 | −138 964 | 6 966 432 |
2012-03-26 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −5 000 | 255 656 | −1,92 | 30,07 | −150 336 | 7 686 886 |
2012-03-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −5 000 | 255 656 | −1,92 | 30,07 | −150 336 | 7 686 886 |
2012-02-27 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −5 000 | 260 656 | −1,88 | 28,85 | −144 255 | 7 520 186 |
2012-02-27 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −5 000 | 265 656 | −1,85 | 28,15 | −140 740 | 7 477 685 |
2012-02-17 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
F - Taxes | −1 396 | 18 604 | −6,98 | 28,97 | −40 442 | 538 958 | |
2012-02-17 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
G - Gift | −936 | 270 656 | −0,34 | ||||
2012-02-17 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
G - Gift | 936 | 14 770 | 6,77 | ||||
2012-02-17 |
|
5 | GHDX |
GENOMIC HEALTH INC
Common Stock |
G - Gift | −350 | 281 592 | −0,12 | ||||
2012-02-17 |
|
5 | GHDX |
GENOMIC HEALTH INC
Common Stock |
G - Gift | −100 | 281 942 | −0,04 | ||||
2012-02-17 |
|
5 | GHDX |
GENOMIC HEALTH INC
Common Stock |
G - Gift | −500 | 282 042 | −0,18 | ||||
2012-02-17 |
|
5 | GHDX |
GENOMIC HEALTH INC
Common Stock |
G - Gift | −750 | 282 542 | −0,26 | ||||
2012-02-08 |
|
4/A | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 10 000 | 20 000 | 100,00 | ||||
2012-02-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Employee Stock Option (right to buy) |
A - Award | 90 000 | 90 000 | |||||
2012-02-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 10 000 | 20 000 | 100,00 | ||||
2012-01-26 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −5 000 | 273 292 | −1,80 | 26,42 | −132 084 | 7 219 527 |
2012-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | X | −5 000 | 278 292 | −1,76 | 26,62 | −133 078 | 7 406 936 |